SCHEMBL30231679

SCHEMBL30231679

COC[C@@H](Oc1ccc2c(-c3ccccc3C)cc(=O)oc2c1)C(=O)OC

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.59
▸ HPGD P15428 10/20 0.59
▸ KDM4E B2RXH2 5/20 0.59
▸ HTT P42858 2/20 0.59
▸ HSD17B10 Q99714 2/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ ALDH2 P05091 1/20 0.53
▸ AR P10275 2/20 0.51
▸ RECQL P46063 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ IGLV6-57 P01721 3/20 0.46
▸ USP2 O75604 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ KCNA3 P22001 1/20 0.44
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30231379 1.00 ALDH1A1 (0.59) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231486 1.00 ALDH1A1 (0.59) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231415 0.91 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231699 0.91 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231414 0.91 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231271 0.91 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231519 0.91 ALDH1A1 (0.60) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231666 0.91 ALDH1A1 (0.60) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231326 0.91 ALDH1A1 (0.60) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL30231874 0.90 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368106-A1 HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2024-11-07 — — US disclosed
WO-2023034340-A1 HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed
WO-2023034339-A1 HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368106-A1 HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT POLRMT, ACAT1, TFAM ALDH1A1 909/4885HPGD 882/4885KDM4E 2584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback